Yinlu Ding

867 total citations
33 papers, 559 citations indexed

About

Yinlu Ding is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Yinlu Ding has authored 33 papers receiving a total of 559 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 15 papers in Oncology and 10 papers in Cell Biology. Recurrent topics in Yinlu Ding's work include Hippo pathway signaling and YAP/TAZ (10 papers), Ubiquitin and proteasome pathways (9 papers) and Cancer-related Molecular Pathways (5 papers). Yinlu Ding is often cited by papers focused on Hippo pathway signaling and YAP/TAZ (10 papers), Ubiquitin and proteasome pathways (9 papers) and Cancer-related Molecular Pathways (5 papers). Yinlu Ding collaborates with scholars based in China, United States and Sweden. Yinlu Ding's co-authors include Qisan Wang, Jian Zhu, Ting Zhuang, Peng Su, Jianliang Zhang, Lei Xiang, Yong Zhou, Huijie Yang, Cheng Yan and Min Xue and has published in prestigious journals such as Cancer Research, Oncogene and British Journal of Pharmacology.

In The Last Decade

Yinlu Ding

31 papers receiving 551 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yinlu Ding China 15 305 151 108 96 91 33 559
Sine Godiksen Denmark 11 220 0.7× 98 0.6× 58 0.5× 114 1.2× 37 0.4× 12 482
Angela Poehlmann Germany 12 295 1.0× 165 1.1× 66 0.6× 99 1.0× 82 0.9× 13 526
Pei Wu China 10 217 0.7× 178 1.2× 82 0.8× 122 1.3× 100 1.1× 33 505
Junhui Yu China 15 400 1.3× 279 1.8× 157 1.5× 160 1.7× 105 1.2× 33 741
Baozhong Li China 13 391 1.3× 140 0.9× 53 0.5× 247 2.6× 57 0.6× 22 555
Leili Ran United States 6 237 0.8× 75 0.5× 44 0.4× 37 0.4× 137 1.5× 10 497
Caixia Wang China 14 281 0.9× 64 0.4× 78 0.7× 168 1.8× 103 1.1× 30 491
Takahiro Shiraishi Japan 9 395 1.3× 200 1.3× 52 0.5× 144 1.5× 71 0.8× 45 595
Kiyohito Kato Japan 17 505 1.7× 296 2.0× 221 2.0× 230 2.4× 148 1.6× 31 791
Masaya Nomura Japan 7 372 1.2× 119 0.8× 97 0.9× 50 0.5× 35 0.4× 28 585

Countries citing papers authored by Yinlu Ding

Since Specialization
Citations

This map shows the geographic impact of Yinlu Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yinlu Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yinlu Ding more than expected).

Fields of papers citing papers by Yinlu Ding

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yinlu Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yinlu Ding. The network helps show where Yinlu Ding may publish in the future.

Co-authorship network of co-authors of Yinlu Ding

This figure shows the co-authorship network connecting the top 25 collaborators of Yinlu Ding. A scholar is included among the top collaborators of Yinlu Ding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yinlu Ding. Yinlu Ding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Huijie, Jin Cui, Peng Su, et al.. (2025). Oxytocin Receptor Regulates the Hippo/YAP Axis to Drive Hepatocarcinogenesis. Cancer Research. 85(19). 3752–3770.
2.
Sun, Yanan, Dongyi Liu, Xiaobo Zhang, et al.. (2024). Regulation of Hippo/YAP axis in colon cancer progression by the deubiquitinase JOSD1. Cell Death Discovery. 10(1). 365–365. 6 indexed citations
3.
Zhang, Peng, et al.. (2024). USP12 facilitates gastric cancer progression via stabilizing YAP. Cell Death Discovery. 10(1). 174–174. 6 indexed citations
4.
Wang, Tianshi, Dehai Wang, Yanan Sun, et al.. (2023). Regulation of the Hippo/YAP axis by CXCR7 in the tumorigenesis of gastric cancer. Journal of Experimental & Clinical Cancer Research. 42(1). 297–297. 14 indexed citations
5.
Li, Quanhui, Xin Li, Zhongbo Li, et al.. (2023). USP1 modulates hepatocellular carcinoma progression via the Hippo/TAZ axis. Cell Death and Disease. 14(4). 264–264. 22 indexed citations
6.
Zhuang, Ting, Beibei Wang, Le Wu, et al.. (2022). TRIM3 facilitates estrogen signaling and modulates breast cancer cell progression. Cell Communication and Signaling. 20(1). 45–45. 9 indexed citations
7.
Yang, Huijie, Min Xue, Peng Su, et al.. (2022). RNF31 represses cell progression and immune evasion via YAP/PD-L1 suppression in triple negative breast Cancer. Journal of Experimental & Clinical Cancer Research. 41(1). 364–364. 17 indexed citations
8.
Xue, Ying, et al.. (2022). Revisiting the 8th AJCC system for gastric cancer: A review on validations, nomograms, lymph nodes impact, and proposed modifications. Annals of Medicine and Surgery. 75. 103411–103411. 28 indexed citations
9.
Niu, Zhiguo, Xin Li, Shuxiao Dong, et al.. (2021). The E3 Ubiquitin Ligase HOIP inhibits Cancer Cell Apoptosis via modulating PTEN stability. Journal of Cancer. 12(21). 6553–6562. 7 indexed citations
10.
Liu, Yun, Peng Su, Xin Li, et al.. (2021). ZNF213 negatively controls triple negative breast cancer progression via Hippo/YAP signaling. Cancer Science. 112(7). 2714–2727. 10 indexed citations
11.
Zhou, Wei, et al.. (2020). Initial experience of single-incision plus one port left-side approach totally laparoscopic distal gastrectomy with uncut Roux-en-Y reconstruction. World Journal of Gastroenterology. 26(31). 4669–4679. 11 indexed citations
12.
Niu, Zhiguo, Xin Li, Qingsong Huang, et al.. (2020). The deubiquitinating enzyme USP1 modulates ERα and modulates breast cancer progression. Journal of Cancer. 11(23). 6992–7000. 29 indexed citations
13.
Zhou, Rui, Yinlu Ding, Min Xue, Bin Xiong, & Ting Zhuang. (2020). RNF181 modulates Hippo signaling and triple negative breast cancer progression. Cancer Cell International. 20(1). 291–291. 14 indexed citations
14.
Zhu, Jian, et al.. (2020). The ubiquitin ligase RNF181 stabilizes ERα and modulates breast cancer progression. Oncogene. 39(44). 6776–6788. 25 indexed citations
16.
Zhou, Yong, et al.. (2018). Overexpression of S100A4 protein may be associated with the development and progression of pancreatic cancer. Journal of Cancer Research and Therapeutics. 14(Suppl 1). S159–S166. 15 indexed citations
17.
Ding, Yinlu, et al.. (2012). Laparoscopic Management of Perforated Meckel's Diverticulum in Adults. International Journal of Medical Sciences. 9(3). 243–247. 46 indexed citations
18.
Ding, Yinlu, et al.. (2012). Expression of Glioma-associated Oncogene Homolog 1 is Associated with Invasion and Postoperative Liver Metastasis in Colon Cancer. International Journal of Medical Sciences. 9(5). 334–338. 21 indexed citations
19.
Muramoto, Kazuyo, Yinlu Ding, Hua Yang, et al.. (2010). A novel antagonist of the prostaglandin E2 EP4 receptor inhibits Th1 differentiation and Th17 expansion and is orally active in arthritis models. British Journal of Pharmacology. 160(2). 292–310. 84 indexed citations
20.
Wang, Mu‐Chun, Xue Li, Qi Cao, et al.. (2009). Expression of Notch1, Jagged1 and β-catenin and their clinicopathological significance in hepatocellular carcinoma. Neoplasma. 56(6). 533–541. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026